Actively Recruiting
Continuous Glucose Monitor for Mayo Clinic Advanced Care at Home Patients
Led by Mayo Clinic · Updated on 2025-06-04
100
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to measure differences in diabetes control with the use of continuous glucose monitor (CGM) and diabetes education compared with standard of care for glucose monitoring (glucometer checks) and diabetes education in participants with diabetes mellitus receiving therapy with insulin and being admitted to Mayo Clinic Advanced Care at Home Program (ACH).
CONDITIONS
Official Title
Continuous Glucose Monitor for Mayo Clinic Advanced Care at Home Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who are admitted to Advanced Care at Home (ACH) Program and supposed to remain in ACH for at least 72 hours.
- Patients with previous diagnosis of DM type 1 or type 2.
- Patients taking subcutaneous (SQ) insulin either via multidose injections or SQ insulin pump.
- Capable of giving signed informed consent
You will not qualify if you...
- Actively treated for diabetes ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS).
- Participants taking acetaminophen more than 4g per day or more than 1gm every 6 hours.
- Participants with altered mental status.
- Participants diagnosed with dementia.
- Patients with suicidal ideations or experiencing suicidal behavior.
- Patients with liver cirrhosis.
- Patients with End Stage Renal Disease on dialysis bot hemodialysis or peritoneal dialysis.
- Participants with allergy to medical grade adhesive or medical tape.
- Participants taking hydroxyurea.
- Participants who are pregnant, wanting to become pregnant, or nursing during study period.
- Patients with a planned MRI within the following 10 days after admission to ACH.
- Participants currently using continuous glucose monitor (CGM) to dose insulin or check glucose level.
- Participants with diabetes mellitus (DM) treated with diet alone.
- Participants with DM treated with oral hypoglycemic medications.
- Participants with DM treated with one SQ insulin injection daily.
- Participants enrolled in other studies addressing CGM use.
- Participants physically or emotionally incapable of handling a cell phone with a smart display.
- Participants with hearing impaired to a degree that they are not able to hear a smart phone alert or alarm.
- Patients lacking WIFI or Cellular coverage needed to connect the monitoring cell phone to Internet network.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here